Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -7.33% is 74% above its 5-year average of -27.92%, near the high end of its 5-year range (-71.63%–-0.32%).
21.18% above its 12-month average of -9.30%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -5.40%.
OPERATING MARGIN
-7.33%
OPERATING MARGIN AVG TTM
-9.30%
OPERATING MARGIN AVG 3Y
-15.01%
OPERATING MARGIN AVG 5Y
-27.92%
OPERATING MARGIN AVG 10Y
-18.57%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+21.18%
CURRENT VS 3Y AVG
+51.16%
CURRENT VS 5Y AVG
+73.75%
CURRENT VS 10Y AVG
+60.53%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Evolus, Inc.
Market Cap
$486.65M
Operating Margin
-7.33%
TTM Avg
-9.30%
3Y Avg
-15.01%
5Y Avg
-27.92%
Market Cap
$485.58M
Operating Margin
13.16%
TTM Avg
14.88%
3Y Avg
13.50%
5Y Avg
6.84%
Market Cap
$475.51M
Operating Margin
-43.75%
TTM Avg
-69.37%
3Y Avg
-212.63%
5Y Avg
-278.07%
Market Cap
$475.26M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$497.37M
Operating Margin
0.00%
TTM Avg
-5335.57%
3Y Avg
-2667.78%
5Y Avg
-1778.52%
Market Cap
$475.02M
Operating Margin
-36.19%
TTM Avg
-55.58%
3Y Avg
-82.00%
5Y Avg
-57.61%
Market Cap
$473.27M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-8.04%
5Y Avg
-6.43%
Market Cap
$474.59M
Operating Margin
-0.73%
TTM Avg
-6.05%
3Y Avg
-13.09%
5Y Avg
-25.54%
Market Cap
$500.41M
Operating Margin
10.00%
TTM Avg
8.23%
3Y Avg
4.46%
5Y Avg
2.51%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evolus, Inc. (EOLS) | $486.65M | -7.33% | -9.30% | -15.01% | -27.92% |
| Puma Biotechnology, Inc. (PBYI)vs › | $485.58M | 13.16% | 14.88% | 13.50% | 6.84% |
| Arvinas, Inc. (ARVN)vs › | $475.51M | -43.75% | -69.37% | -212.63% | -278.07% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $475.26M | 0.00% | 0.00% | 0.00% | 0.00% |
| Oculis Holding AG (OCS)vs › | $497.37M | 0.00% | -5335.57% | -2667.78% | -1778.52% |
| Alpha Teknova, Inc. (TKNO)vs › | $475.02M | -36.19% | -55.58% | -82.00% | -57.61% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $473.27M | 0.00% | 0.00% | -8.04% | -6.43% |
| Cerus Corporation (CERS)vs › | $474.59M | -0.73% | -6.05% | -13.09% | -25.54% |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.41M | 10.00% | 8.23% | 4.46% | 2.51% |
| Kamada Ltd. (KMDA)vs › | $470.50M | 14.51% | 13.50% | 9.39% | 8.55% |
Gross Margin
66.3%
Operating Margin
-7.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -5.40% |
| 2026-03-31 | -9.38% |
| 2025-12-31 | -0.32% |
| 2025-09-30 | -16.67% |
| 2025-06-30 | -14.71% |
| 2025-03-31 | -22.14% |
| 2024-12-31 | -2.93% |
| 2024-09-30 | -25.33% |
| 2024-06-30 | -11.51% |
| 2024-03-31 | -15.04% |
| 2023-12-31 | -14.16% |
| 2023-09-30 | -26.87% |
| 2023-06-30 | -30.64% |
| 2023-03-31 | -28.86% |
| 2022-12-31 | -24.37% |
| 2022-09-30 | -52.80% |
| 2022-06-30 | -57.44% |
| 2022-03-31 | -45.56% |
| 2021-12-31 | -52.02% |
| 2021-09-30 | -71.63% |
| 2021-06-30 | -58.60% |
| 2021-03-31 | 65.57% |
| 2020-12-31 | -524.98% |
| 2020-09-30 | -63.59% |
| 2020-06-30 | -172.92% |
| 2020-03-31 | -259.90% |
| 2019-12-31 | -84.13% |
| 2019-09-30 | -190.92% |
| 2019-06-30 | -1557.64% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
